Marico's (MRCO) 2QFY21 earnings were largely in line, barring the 11% volume growth (v/s est. 7.3%). Over the past year, MRCO has witnessed remarkable recovery in its key segments Parachute, Saffola and more recently in case of VAHO. Importantly, the outlook remains strong with guidance of 8-10% volume growth in 2HFY21 as well. While the stock is up 40% since our upgrade in Mar'20, robust sales outlook and inexpensive valuations (37x FY22E, 20% discount to peer average),...